Liquidia (LQDA) Gross Margin (2020 - 2026)

Liquidia (LQDA) recorded quarterly Gross Margin of 91.66% in Q1 2026, down 1.57% quarter-over-quarter from 93.13% in Q4 2025, and up 4028.0% on a YoY basis from 2.22% in Q1 2025.

Liquidia (LQDA) Gross Margin (2020 - 2026) Analysis & Trends

Liquidia's Gross Margin history runs 7 years deep, the most recent figure standing at 91.66% for Q1 2026.

  • In Q1 2026, Gross Margin rose 4028.0% year-over-year to 91.66%; the TTM figure through Mar 2026 stood at 93.58% (up 3550.0% YoY), while the FY2025 annual figure was 94.43%, up 3643.0% from the prior year.
  • Gross Margin was 91.66% for Q1 2026 at Liquidia, down from 93.13% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 98.38% in Q3 2025 to a low of 50.64% in Q1 2024.
  • Historically, Gross Margin has averaged 77.62% across 5 years, with a median of 81.34% in 2022.
  • The sharpest annual moves came in 2024 and 2026: Gross Margin sank 3480 bps in 2024, then soared 4028 bps in 2026.
  • A 5-year view of Gross Margin shows it stood at 87.05% in 2022, then decreased by 10 bps to 78.08% in 2023, then slumped by 31 bps to 53.58% in 2024, then surged by 74 bps to 93.13% in 2025, then decreased by 2 bps to 91.66% in 2026.
  • The last three Gross Margin figures came in at 91.66% (Q1 2026), 93.13% (Q4 2025), and 98.38% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 49.52%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 71.66%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 82.93%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 49.50%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 98.31%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.26%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -293.83%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 61.20%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 65.25%
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 91.66%

Historic Data

Download Data
DateValue
Mar 31, 2026 91.66%
Dec 31, 2025 93.13%
Sep 30, 2025 98.38%
Jun 30, 2025 97.68%
Mar 31, 2025 51.38%
Dec 31, 2024 53.58%
Sep 30, 2024 64.82%
Jun 30, 2024 59.20%
Mar 31, 2024 50.64%
Dec 31, 2023 78.08%
Sep 30, 2023 84.50%
Jun 30, 2023 85.98%
Mar 31, 2023 85.44%
Dec 31, 2022 87.05%
Sep 30, 2022 76.62%
Jun 30, 2022 81.34%
Mar 31, 2022 80.13%
Dec 31, 2021 77.42%
Sep 30, 2021 72.00%
Jun 30, 2021 78.85%